berberine has been researched along with Autoimmune Diabetes in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Latent autoimmune diabetes in adults (LADA) is a heterogeneous form of diabetes, characterized by autoimmune destruction of pancreatic β-cells as well as insulin resistance and is triggered by environmental factors in the context of genetic susceptibility." | 7.11 | Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial. ( Mei, Z; Wu, X; Xiao, Y; Yan, J; Yang, W; Zhang, R; Zhou, Z, 2022) |
| "In animal models, treatment of type 2 diabetes mellitus rats with BBR lowered fasting blood glucose and fasting serum insulin, increased insulin sensitivity, and elevated InsR mRNA as well as PKC activity in the liver." | 5.35 | Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. ( Jiang, JD; Kong, WJ; Li, ZR; Pan, HN; Shan, N; Si, SY; Song, DQ; Wang, YM; Wei, J; Xue, R; Yang, P; You, XF; Zhang, H; Zhao, LX; Zhao, W; Zhou, ZX, 2009) |
| "Latent autoimmune diabetes in adults (LADA) is a heterogeneous form of diabetes, characterized by autoimmune destruction of pancreatic β-cells as well as insulin resistance and is triggered by environmental factors in the context of genetic susceptibility." | 3.11 | Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial. ( Mei, Z; Wu, X; Xiao, Y; Yan, J; Yang, W; Zhang, R; Zhou, Z, 2022) |
| "Berberine (BBR) can ameliorate type 2 diabetes and insulin resistance in many ways." | 1.91 | Berberine Regulates GPX4 to Inhibit Ferroptosis of Islet β Cells. ( Bao, L; Han, J; Jin, Y; Qian, L; Wang, W; Wu, W, 2023) |
| "Berberine is a compound for which both antidiabetic and antiosteoporotic effects have been documented." | 1.72 | Lack of berberine effect on bone mechanical properties in rats with experimentally induced diabetes. ( Cegieła, U; Folwarczna, J; Gajdoš, M; Janas, A; Kisiel-Nawrot, E; Kocik, S; Krivošíková, Z; Londzin, P; Skoczyńska, A; Štefíková, K, 2022) |
| "In animal models, treatment of type 2 diabetes mellitus rats with BBR lowered fasting blood glucose and fasting serum insulin, increased insulin sensitivity, and elevated InsR mRNA as well as PKC activity in the liver." | 1.35 | Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. ( Jiang, JD; Kong, WJ; Li, ZR; Pan, HN; Shan, N; Si, SY; Song, DQ; Wang, YM; Wei, J; Xue, R; Yang, P; You, XF; Zhang, H; Zhao, LX; Zhao, W; Zhou, ZX, 2009) |
| "Because type 1 diabetes is caused by T cell-mediated destruction of beta cells and severe islet inflammation, we hypothesized that berberine could ameliorate type 1 diabetes through its immune regulation properties." | 1.35 | Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. ( Cui, G; Ge, B; Gong, Z; Qin, X; Zang, YQ; Zhang, Y, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Londzin, P | 1 |
| Kocik, S | 1 |
| Kisiel-Nawrot, E | 1 |
| Janas, A | 1 |
| Skoczyńska, A | 1 |
| Krivošíková, Z | 1 |
| Štefíková, K | 1 |
| Gajdoš, M | 1 |
| Cegieła, U | 1 |
| Folwarczna, J | 1 |
| Zhang, R | 1 |
| Xiao, Y | 1 |
| Yan, J | 1 |
| Yang, W | 1 |
| Wu, X | 1 |
| Mei, Z | 1 |
| Zhou, Z | 1 |
| Bao, L | 1 |
| Jin, Y | 1 |
| Han, J | 1 |
| Wang, W | 1 |
| Qian, L | 1 |
| Wu, W | 1 |
| Sun, J | 1 |
| Bao, H | 1 |
| Peng, Y | 1 |
| Zhang, H | 3 |
| Sun, Y | 1 |
| Qi, J | 1 |
| Gao, Y | 1 |
| Kong, WJ | 1 |
| Song, DQ | 1 |
| Xue, R | 1 |
| Zhao, W | 1 |
| Wei, J | 1 |
| Wang, YM | 1 |
| Shan, N | 1 |
| Zhou, ZX | 1 |
| Yang, P | 1 |
| You, XF | 1 |
| Li, ZR | 1 |
| Si, SY | 1 |
| Zhao, LX | 1 |
| Pan, HN | 1 |
| Jiang, JD | 1 |
| Cui, G | 1 |
| Qin, X | 1 |
| Zhang, Y | 1 |
| Gong, Z | 1 |
| Ge, B | 1 |
| Zang, YQ | 1 |
| Chueh, WH | 2 |
| Lin, JY | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: A Randomized Controlled Trial[NCT04698330] | Phase 4 | 240 participants (Anticipated) | Interventional | 2022-05-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for berberine and Autoimmune Diabetes
| Article | Year |
|---|---|
Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial.
Topics: Adult; Berberine; Diabetes Mellitus, Type 1; Glucose Intolerance; Humans; Insulin; Inulin; Latent Au | 2022 |
7 other studies available for berberine and Autoimmune Diabetes
| Article | Year |
|---|---|
Lack of berberine effect on bone mechanical properties in rats with experimentally induced diabetes.
Topics: Animals; Berberine; Bone Density; Bone Remodeling; Diabetes Mellitus, Experimental; Diabetes Mellitu | 2022 |
Berberine Regulates GPX4 to Inhibit Ferroptosis of Islet β Cells.
Topics: Berberine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Ferroptosis; Reactive Oxygen Specie | 2023 |
Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; B | 2018 |
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Topics: Animals; Berberine; Cell Line, Tumor; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; | 2009 |
Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice.
Topics: Animals; Berberine; Cell Differentiation; Cytokines; Diabetes Mellitus, Type 1; Disease Models, Anim | 2009 |
Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice.
Topics: Animals; Berberine; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 1; Disease Models, A | 2011 |
Protective effect of berberine on serum glucose levels in non-obese diabetic mice.
Topics: Animals; Berberine; Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Energy Intake; Female; Gl | 2012 |